Company Profile

StabiLux Biosciences Inc
Profile last edited on: 10/31/18      CAGE: 79KC4      UEI: TGVWGK6GC341

Business Identifier: High-brightness fluorophores
Year Founded
2014
First Award
2015
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

22151 Ridge Road
Houghton, MI 49931
   (906) 487-2900
   N/A
   www.stabiluxbiosciences.com
Location: Single
Congr. District: 01
County: Houghton

Public Profile

StabiLux Biosciences is a Michigan Technological University (MTU) spinoff company developing proprietary, high-brightness fluorophores targeted at biomedical applications, particularly for use in multi-color flow cytometry. A staple of biological research and clinical diagnostics Flow cytometry is a laser based fluorescence technique for medical diagnostics and cell analysis and sorting. Flow cytometry is capable of utilizing 18 simultaneous color channels, but current reagents on effectively mark a few colors at a time. Current flow cytometry is limited by: Weak signals from low abundant cells, Spillover (signal overlapping) and Autofluorescence (background noise) Though current flow cytometer allows for such multi-color applications, existing fluorophore reagent technology inhibits utilization of the hardware to its full potential. If more colors could be effectively used, more subsets of data could be attained for a given test run, improving data output and accelerating time to market for researchers and medical diagnostic discovery. StabiLux has developed proprietary, high-brightness fluorophores which improves the reagents that run through flow cytometers. The firm's platform technology will apply to all color channels and is compatible with current flow cytometers, eliminating the need for any additional equipment. This would enable Researchers to sort cells more effectively and attain more data subsets within a given test run - sigificantly reducing time required. Additionally, equipment manufacturers are releasing higher end flow cytometry that requires even more reagent capability. Stabilux fluorophores can now create reagents that can be specified with these new machines.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NSF $1,758,997
Project Title: High Brightness Fluorophores for Bioscience Applications
2020 1 NSF $256,000
Project Title: COVID-19 - High-Brightness Fluorescent Probes for Quantitative Polymerase Chain Reaction

Key People / Management

  Xiuling Liu

  Yoke Khin Yap -- Founder

  Nazmiye Yapici -- Principal Scientist